These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10404787)

  • 1. Which DVT patients could be considered the best candidates for home therapy?
    Monreal M
    Thromb Haemost; 1999 Jun; 81(6):996-7. PubMed ID: 10404787
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin after deep venous thrombosis. Even the first injection the patient can administer himself].
    MMW Fortschr Med; 1999 Dec; 141(51-52):62. PubMed ID: 10949629
    [No Abstract]   [Full Text] [Related]  

  • 3. Outpatient therapy with low-molecular-weight heparins: new perspectives for treatment of deep vein thrombosis.
    Büller HR
    Haemostasis; 1998; 28 Suppl 3():91-4. PubMed ID: 10069767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of deep venous thrombosis].
    Mesters RM
    Internist (Berl); 1999 Oct; 40(10):1098-9. PubMed ID: 10610366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of a patient with an undefined hypercoagulable state with long-term low-molecular-weight heparin.
    Dobie SA; Ellsworth AJ; Linenberger ML
    West J Med; 1996 Apr; 164(4):350-3. PubMed ID: 8732743
    [No Abstract]   [Full Text] [Related]  

  • 7. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview.
    Matsagas MI
    Int Angiol; 2004 Dec; 23(4):305-16. PubMed ID: 15767978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].
    Kock HJ; Schmit-Neuerburg KP; Hanke J; Hakmann A; Althoff M; Rudofski G
    Vasa Suppl; 1992; 35():105-6. PubMed ID: 1336215
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protocol for ambulant treatment of deep venous thrombosis in a leg: efficacious and safe in general practice].
    van Hulsteijn LH; Brenninkmeijer BJ; Trügg RA; Litjens-van de Ven AJ; Huisman MV
    Ned Tijdschr Geneeskd; 2000 Mar; 144(12):557-60. PubMed ID: 10746047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term thromboprophylaxis in practice: how can it be implemented?
    Nurmohamed MT; MacGillavry MR
    Orthopedics; 2000 Jun; 23(6 Suppl):s647-50. PubMed ID: 10875430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DVT treatment in 2000: state of the art.
    Davidson BL
    Orthopedics; 2000 Jun; 23(6 Suppl):s651-4. PubMed ID: 10875431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute superficial thrombophlebitis--therapeutic strategies].
    Noppeney T; Noppeney J; Winkler M; Kurth I
    Zentralbl Chir; 2006 Feb; 131(1):51-6. PubMed ID: 16485211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: a systematic review.
    Falagas ME; Vardakas KZ; Athanasiou S
    Eur J Pharmacol; 2007 Feb; 557(2-3):93-8. PubMed ID: 17222406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in patient self-management of subcutaneous drug application: removal of rubber protection caps from ready-to-use syringes.
    Mengiardi S; Goepfert B; Tsakiris DA; Hersberger KE
    Eur J Clin Pharmacol; 2009 Oct; 65(10):1061-2. PubMed ID: 19536529
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.